CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 8-K Event Material agreement · New debt or obligation
- 4 Shares withheld for taxes CEO and President gave up 99 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 97 shares (to pay taxes)
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy SVP, General Counsel bought 14,000 shares at $1.54 ($21,624)
- 4 Open-market buy SVP-Bus. Process & Info. Tech. bought 2,000 shares at $1.50 ($3,000)
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 5,066 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 4,729 shares (to pay taxes)
- 4/A Shares withheld for taxes CEO and President gave up 149 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Innovation/Tech Officer gave up 147 shares (to pay taxes)
Page 26 of 35 · 690 filings